BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Agenus (Formerly known as Antigenics Inc. - New York) 

Corporate Headquarters
3 Forbes Road
Lexington  Massachusetts  02421-7305  U.S.A.
Phone: 781-674-4400 Fax: 781-674-4200


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Biotechnology





 Company News
Agenus (AGEN) Reports Second Quarter 2014 Financial Results 7/24/2014 11:23:32 AM
Massachusetts' Agenus (AGEN) Touts Positive Phase 2 Data From HerpV Study 6/26/2014 6:02:11 AM
Agenus (Formerly known as Antigenics Inc. - New York) (AGEN) Completes Acquisition of 4-Antibody AG 2/13/2014 8:16:39 AM
Agenus (Formerly known as Antigenics Inc. - New York) (AGEN)’ Prophage Vaccine For Glioma Hailed As A "Very Promising Therapy" In An Editorial Published In The Journal Neuro-Oncology 1/21/2014 9:11:33 AM
Agenus (Formerly known as Antigenics Inc. - New York) (AGEN) To Present At OneMedForum San Francisco 2014 1/9/2014 7:01:29 AM
Agenus (Formerly known as Antigenics Inc. - New York) (AGEN)' Brain Cancer Vaccine Program Named A "Top Project To Watch" By Elsevier Business Intelligence 11/18/2013 9:55:46 AM
Agenus Reports Third Quarter 2013 Financial Results 10/24/2013 7:02:17 AM
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) Reports Positive Follow-on Phase 2 Results for Brain Cancer Vaccine in Newly Diagnosed Patients 9/17/2013 10:57:34 AM
New Phase 2 Data From Brain Cancer Study With Agenus (Formerly known as Antigenics Inc. - New York) (AGEN)' Prophage Vaccine (HSPPC-96) Presented at Plenary Session of AANS 4/17/2012 9:41:30 AM
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) and NewVac Enter Into Agreement in the Area of Personalized Cancer Vaccines 12/20/2011 8:51:33 AM
12345678910...